Literature DB >> 7735688

Structural requirements at the melatonin receptor.

D Sugden1, N W Chong, D F Lewis.   

Abstract

1. High affinity, specific binding sites for the pineal hormone, melatonin (5-methoxy N-acetyltryptamine) can be detected in chick brain membranes by use of the radiolabelled agonist, 2-[125I]-iodomelatonin (2-[125I]-aMT). 2. The affinity of a number of analogues of melatonin at the 2-[125I]-aMT binding site was determined and compared with an analysis of their electronic structure and significant quantitative relationships obtained. 3. The best correlations indicated that binding affinity was correlated with delta E, the difference between the frontier orbital energies, and QNH, the electron density in the highest occupied molecular orbital of the side-chain nitrogen atom. 4. These findings suggest that ligand binding may involve hydrogen bonding between the 5-methoxy and amide moieties of melatonin and complementary amino acid residues, and charge transfer interactions between the indole ring of melatonin and an aromatic amino acid in the receptor binding site. 5. A molecular model of a putative binding site is proposed based on the predicted amino acid sequence of the cloned Xenopus laevis melanophore melatonin receptor and the quantitative structure-affinity relationships observed in the present study.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7735688      PMCID: PMC1510016          DOI: 10.1111/j.1476-5381.1995.tb17184.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  30 in total

1.  Characterization of 2-[125I]iodomelatonin binding sites in the brain of a marsupial, Bennett's wallaby (Macropus rufogriseus rufogriseus).

Authors:  A Paterson; N W Chong; B R Brinklow; A S Loudon; D Sugden
Journal:  Comp Biochem Physiol Comp Physiol       Date:  1992-05

2.  Novel naphthalenic ligands with high affinity for the melatonin receptor.

Authors:  S Yous; J Andrieux; H E Howell; P J Morgan; P Renard; B Pfeiffer; D Lesieur; B Guardiola-Lemaitre
Journal:  J Med Chem       Date:  1992-04-17       Impact factor: 7.446

Review 3.  Melatonin receptors.

Authors:  D N Krause; M L Dubocovich
Journal:  Annu Rev Pharmacol Toxicol       Date:  1991       Impact factor: 13.820

4.  Quantitative structure-activity relationships within a series of melatonin analogs and related indolealkylamines.

Authors:  D F Lewis; J Arendt; J English
Journal:  J Pharmacol Exp Ther       Date:  1990-01       Impact factor: 4.030

5.  Aggregation of pigment granules in single cultured Xenopus laevis melanophores by melatonin analogues.

Authors:  D Sugden
Journal:  Br J Pharmacol       Date:  1991-12       Impact factor: 8.739

6.  Pharmacological identity of 2-[125I]iodomelatonin binding sites in chicken brain and sheep pars tuberalis.

Authors:  D Sugden; N W Chong
Journal:  Brain Res       Date:  1991-01-18       Impact factor: 3.252

7.  Melatonin inhibits gonadotropin-releasing hormone-induced elevation of intracellular Ca2+ in neonatal rat pituitary cells.

Authors:  J Vanecek; D C Klein
Journal:  Endocrinology       Date:  1992-02       Impact factor: 4.736

8.  2-Amido-8-methoxytetralins: a series of nonindolic melatonin-like agents.

Authors:  S Copinga; P G Tepper; C J Grol; A S Horn; M L Dubocovich
Journal:  J Med Chem       Date:  1993-10-01       Impact factor: 7.446

9.  Sleep laboratory investigations on hypnotic properties of melatonin.

Authors:  F Waldhauser; B Saletu; I Trinchard-Lugan
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

10.  Melatonin stabilises sleep onset time in a blind man without entrainment of cortisol or temperature rhythms.

Authors:  S Folkard; J Arendt; M Aldhous; H Kennett
Journal:  Neurosci Lett       Date:  1990-05-31       Impact factor: 3.046

View more
  5 in total

Review 1.  Update on melatonin receptors: IUPHAR Review 20.

Authors:  Ralf Jockers; Philippe Delagrange; Margarita L Dubocovich; Regina P Markus; Nicolas Renault; Gianluca Tosini; Erika Cecon; Darius P Zlotos
Journal:  Br J Pharmacol       Date:  2016-08-08       Impact factor: 8.739

2.  Daily Rhythm in Plasma N-acetyltryptamine.

Authors:  Peter S Backlund; Henryk F Urbanski; Mark A Doll; David W Hein; Marjan Bozinoski; Christopher E Mason; Steven L Coon; David C Klein
Journal:  J Biol Rhythms       Date:  2017-05-03       Impact factor: 3.182

3.  International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors.

Authors:  Margarita L Dubocovich; Philippe Delagrange; Diana N Krause; David Sugden; Daniel P Cardinali; James Olcese
Journal:  Pharmacol Rev       Date:  2010-07-06       Impact factor: 25.468

Review 4.  A molecular and chemical perspective in defining melatonin receptor subtype selectivity.

Authors:  King Hang Chan; Yung Hou Wong
Journal:  Int J Mol Sci       Date:  2013-09-06       Impact factor: 5.923

5.  New quinoxaline derivatives as potential MT₁ and MT₂ receptor ligands.

Authors:  Saioa Ancizu; Nerea Castrillo; Silvia Pérez-Silanes; Ignacio Aldana; Antonio Monge; Philippe Delagrange; Daniel-Henry Caignard; Silvia Galiano
Journal:  Molecules       Date:  2012-06-25       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.